However, it has been recently proposed that tissue-resident memory CD8+ T (CD8+ Trm) cells have a role in controlling liver fibrosis during the resolution of experimental NASH. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.